Sci­en­tist-turned-VC: Kevin Bit­ter­man takes his biotech hatch­ing ex­pe­ri­ence to a new role at At­las

Kevin Bit­ter­man knows a thing or two about biotech star­tups.

As a part­ner at Po­laris, which spe­cial­izes in cre­at­ing cut­ting edge de­vel­op­ers, he was the found­ing CEO of Ed­i­tas $ED­IT, one of the lead­ers in the gene edit­ing field. He was present at the cre­ation of Mor­phic and co-found­ed Geno­cea $GN­CA, among oth­ers.

And now he tells us he is mov­ing over to At­las Ven­ture, which plays a high pro­file role in kick­start­ing its own biotech ven­tures with a care­ful eye on the po­ten­tial pay­out.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.